KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Diversified Healthcare Trust (DHC) EBITDA (2016 - 2026)

Diversified Healthcare Trust filings provide 18 years of EBITDA readings, the most recent being -$3.9 million for Q1 2026.

  • On a quarterly basis, EBITDA rose 90.72% to -$3.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$199.2 million, a 56.24% decrease, with the full-year FY2025 number at -$261.1 million, down 63.45% from a year prior.
  • EBITDA hit -$3.9 million in Q1 2026 for Diversified Healthcare Trust, up from -$30.3 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $352.9 million in Q1 2022 to a low of -$113.7 million in Q3 2025.
  • Median EBITDA over the past 5 years was $13.6 million (2024), compared with a mean of $19.7 million.
  • Biggest five-year swings in EBITDA: surged 3913.78% in 2023 and later crashed 934.66% in 2025.
  • Diversified Healthcare Trust's EBITDA stood at $49.9 million in 2022, then increased by 5.49% to $52.6 million in 2023, then crashed by 266.79% to -$87.7 million in 2024, then skyrocketed by 65.45% to -$30.3 million in 2025, then surged by 87.2% to -$3.9 million in 2026.
  • The last three reported values for EBITDA were -$3.9 million (Q1 2026), -$30.3 million (Q4 2025), and -$113.7 million (Q3 2025) per Business Quant data.